title: [Menopause and bone].
abstract: Osteoporosis is a diffuse disease of the skeleton characterized by a decrease and a change in bone microarchitecture, which causes excessive fragility of the bone exposing them to increased risk of fracture. It represents a major public health issue, with 200 million people suffering from this disease in the world. The therapeutic goal is to maintain bone mineral density while avoiding the risk of falling.
authors.affiliation: Hôpital Cochin, 27 rue du Faubourg-Saint-Jacques, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Lobersztajn
authors.forename: F
authors.initials: F
authors.lastname: Trémollières
mesh_terms: D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D001842:Bone and Bones / Q000378:metabolism / Q000502:physiology*; D002755:Choice Behavior; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008593:Menopause / Q000378:metabolism / Q000502:physiology*; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D012307:Risk Factors
chemical_list: D050071:Bone Density Conservation Agents